Application of PDGF inhibitor in preparation of medicines for treating intestinal inflammation diseases

A technology of inhibitors and small molecule inhibitors, applied in the field of biomedicine, can solve problems such as the complex mechanism of radiation enteropathy

CN110575540AActive Publication Date: 2019-12-17THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIV
8 Cites 1 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Publication Date
2019-12-17

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention belongs to the field of biological medicine, and relates to application of a PDGF inhibitor in preparation of medicines for treating intestinal inflammation diseases, in particular to application of a PDGFR signal pathway inhibitor in preparation of medicines for treating radiation enteritis. It is found for the first time that both ligands and receptors of PDGFR signal pathways arehighly expressed in intestinal tissues with radiation enteritis. Furthermore, intestinal injuries caused by radiotherapy are effectively relieved by inhibiting the PDGFR signal pathways. The inventionprovides a brand-new idea for treating radiation enteritis.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of biomedicine and relates to the use of PDGF inhibitors in the preparation of medicines for treating intestinal inflammatory diseases, in particular to the application of PDGFR inhibitors in the preparation of medicines for treating radiation enteropathy. Background technique

[0002] Radiation Enteropathy (RE) refers to persistent and repeated radiation intestinal injury in patients with pelvic and abdominal tumors after receiving radiotherapy, and its common symptoms include diarrhea, constipation, abdominal distension, abdominal pain, anal pain, rectal bleeding and fecal incontinence, etc. Symptoms in a small number of patients persist, and serious complications such as intestinal obstruction, perforation, intestinal fistula, and intractable intestinal bleeding may even occur. The main pathological changes of RE include abnormal hyperplasia of mucosal blood vessels, submucosa fibrosis, and obstructive endarteritis...

Examples

Embodiment 1

[0147] Embodiment 1 Animal experiment

[0148] 1.1 Establishment of animal models of radiation enteropathy

[0149] According to existing literature reports, 6-8 week old female C57BL6 / J mice were used as modeling objects. The experimental procedures and animal handling methods complied with the animal experiment guidelines and rules of the Experimental Animal Ethics and Welfare Committee of Sun Yat-sen University.

[0150] (1) Purchase 8-week-old female C57BL6 / J mice from the Animal Experiment Center of Sun Yat-sen University, weighing about 18g-20g, place them in the Animal Experiment Center of the North Campus of Sun Yat-sen University for one week and then irradiate them.

[0151] (2) The mice were ear-marked and numbered one day before irradiation, and the mice were divided into the irradiation group and the control group by using the Excel table to generate random numbers. At the same time, the mice in the two groups were weighed and recorded.

[0152] (3) On the day o...

Embodiment 2

[0171] Embodiment 2 cell culture and processing

[0172] (1) CCD-18Co (human colon fibroblast) cell culture

[0173] Place the CCD-18Co cells preserved in liquid nitrogen in a water bath at 37°C for 3-5 minutes, then resuspend them in DMEM medium containing 10% fetal bovine serum, and store them in 37%, 5% CO 2 Cultured under the condition of 1:3~1:5 when the cells grew to 90% monolayer.

[0174] (2) Crenolanib treatment of CCD-18Co cells

[0175] When the cells grow to 80%-90% monolayer, absorb the culture solution containing 10% fetal bovine serum in the cell culture dish to be treated, add an appropriate amount of serum-free DMEM culture solution to starve overnight, and then add the prepared Crenolainib (CP- 868596) solution (5mM / ml) was added to the DMEM culture solution containing 10% fetal bovine serum, the treatment concentration was adjusted to 1 μM / ml, and the cell protein was collected after continuing to culture for 48 hours.

[0176] (3) Anti-PDGFRα or anti-PDG...

Embodiment 3

[0187] HE, MASSON, immunohistochemical staining and RIS score of embodiment 3 animal tissue

[0188] (1) HE staining

[0189] The mouse intestinal tissue used for HE (hematoxylin-eosin staining) staining was placed in 10% neutral formalin fixative solution for 24 hours, rinsed with running water, dehydrated, transparent, and embedded in paraffin to prepare a 4 μm thick Serial paraffin sections. Paraffin sections were routinely dewaxed to water, stained with hematoxylin at room temperature for 10 minutes, rinsed with tap water for 30-60 seconds; differentiated with 1% hydrochloric acid alcohol for 1 second, rinsed with tap water for 1 minute; stained with eosin at room temperature for 5-10 minutes; dehydrated with gradient alcohol; transparent with xylene; neutral gum cover film.

[0190] (2) MASSON staining

[0191] The intestinal tissues of mice used for MASSON staining were placed in 10% neutral formalin fixative solution for 24 hours, rinsed with running water, dehydrate...